NasdaqGS:SGRYHealthcare
Surgery Partners (SGRY) Is Down 7.3% After Soft 2026 Outlook, Buyback Launch, and New Director
Earlier this month, Surgery Partners, Inc. reported 2025 results showing higher sales of US$885.0 million for the fourth quarter and US$3.31 billion for the year but continuing net losses, issued softer 2026 revenue guidance of US$3.35 billion to US$3.45 billion, launched a new US$200.0 million share repurchase program, and appointed veteran health system executive Lloyd Dean as an independent director.
These developments, alongside pressure from activist investor Ortelius Advisors pushing...